We are live on
!
Find out more
RBCM
Raub Brock Capital Management Portfolio holdings
AUM
$363M
1-Year Est. Return
12.74%
This Fund
S&P 500
This Quarter
Est. Return
+1%
1 Year Est. Return
+12.74%
3 Year Est. Return
+56.31%
5 Year Est. Return
+73.9%
10 Year Est. Return
+299.34%
AUM
$321M
AUM Growth
-$11.9M
(-3.6%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-3.88%
Top 10 Holdings %
Top 10 Hldgs %
42.32%
Holding
39
New
2
Increased
8
Reduced
26
Closed
2
Top Buys
| 1 |
Amgen
AMGN
|
+$12.8M |
| 2 |
CVS Health
CVS
|
+$12.3M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$473K |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$252K |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$137K |
Top Sells
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$14.3M |
| 2 |
Polaris
PII
|
+$11.1M |
| 3 |
Factset
FDS
|
+$2.08M |
| 4 |
UnitedHealth
UNH
|
+$1.58M |
| 5 |
Medtronic
MDT
|
+$1.15M |
Sector Composition
| 1 | Healthcare | 19.8% |
| 2 | Financials | 16% |
| 3 | Industrials | 12.5% |
| 4 | Consumer Discretionary | 7.97% |
| 5 | Consumer Staples | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Accenture
ACN
$87.9B
| $15M | 4.67% |
122,888
-5,993
| -5% | -$682K |
|
|
2
Medtronic
MDT
$106B
| $14.6M | 4.54% |
168,736
-13,233
| -7% | -$1.15M |
|
|
3
UnitedHealth
UNH
$387B
| $14M | 4.37% |
100,324
-11,282
| -10% | -$1.58M |
|
4
Cummins
CMI
$89.5B
| $13.6M | 4.24% |
106,258
-9,275
| -8% | -$1.13M |
|
5
TJX Companies
TJX
$171B
| $13.5M | 4.2% |
361,136
-18,670
| -5% | -$730K |
|
6
Canadian National Railway
CNI
$78.3B
| $13.3M | 4.14% |
203,239
-8,155
| -4% | -$515K |
|
7
Toro Company
TTC
$8.99B
| $13.2M | 4.12% |
282,436
-16,920
| -6% | -$792K |
|
8
Mastercard
MA
$480B
| $13.1M | 4.09% |
128,929
-6,640
| -5% | -$637K |
|
|
9
Factset
FDS
$9.18B
| $12.8M | 3.98% |
78,833
-12,075
| -13% | -$2.08M |
|
10
Hormel Foods
HRL
$14B
| $12.8M | 3.97% |
336,297
-16,710
| -5% | -$621K |
|
|
11
Amgen
AMGN
$198B
| $12.6M | 3.93% |
+75,617
| New | +$12.8M |
|
12
Sherwin-Williams
SHW
$81.7B
| $12.4M | 3.87% |
134,811
-6,351
| -4% | -$616K |
|
13
Toronto Dominion Bank
TD
$204B
| $12.3M | 3.82% |
276,410
-12,320
| -4% | -$540K |
|
14
Nike
NKE
$64.9B
| $12.1M | 3.77% |
229,684
-10,774
| -4% | -$608K |
|
15
Estee Lauder
EL
$29.7B
| $11.8M | 3.66% |
132,800
-5,451
| -4% | -$497K |
|
|
MMP
16
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $11.7M | 3.65% |
165,724
+6,625
| +4% | +$473K |
|
|
SNI
17
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $11.7M | 3.65% |
184,524
-6,390
| -3% | -$409K |
|
|
18
CVS Health
CVS
$137B
| $11.6M | 3.62% |
+130,570
| New | +$12.3M |
|
19
T. Rowe Price
TROW
$25.1B
| $10.8M | 3.37% |
162,644
-1,934
| -1% | -$135K |
|
|
NVO
20
Novo Nordisk
NVO
$223B
| $10.6M | 3.28% |
507,316
-10,270
| -2% | -$255K |
|
21
Vanguard Real Estate ETF
VNQ
$39.6B
| $8.26M | 2.57% |
95,177
+986
| +1% | +$88K |
|
22
Vanguard Total International Bond ETF
BNDX
$82.2B
| $8.19M | 2.55% |
146,172
+1,405
| +1% | +$78.6K |
|
|
23
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
| $7.24M | 2.26% |
159,449
+5,641
| +4% | +$252K |
|
|
24
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $6.89M | 2.14% |
222,530
+4,425
| +2% | +$137K |
|
25
Vanguard Total Bond Market
BND
$159B
| $6.6M | 2.06% |
78,450
+965
| +1% | +$81.2K |
|
Similar funds
MA
IPA
ACM
AFA
RBFC
EW
RGC
VBFP
Raub Brock Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Raub Brock Capital Management held 39 positions worth $321M, down 3.6% from $333M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Raub Brock Capital Management withdrew a net $12.5M in Q3 2016, closing 2 positions and reducing 26 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $14.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
Against the trend, Raub Brock Capital Management opened a new position in Amgen worth $12.6M.
- Raub Brock Capital Management's largest Q3 2016 buy was Amgen: 75,617 shares worth $12.6M.
- Raub Brock Capital Management added most to Magellan Midstream Partners, L.P. in Q3 2016, an estimated $473K increase.
- Raub Brock Capital Management's biggest Q3 2016 reduction was Factset, cutting an estimated $2.08M.
- Raub Brock Capital Management fully exited Walgreens Boots Alliance in Q3 2016, selling an estimated $14.3M.
- Raub Brock Capital Management's ten largest holdings make up 42% of its $321M portfolio in Q3 2016.
- Raub Brock Capital Management opened 2 new positions and closed 2 in Q3 2016.
- Raub Brock Capital Management's portfolio value fell 3.6% quarter-over-quarter to $321M.
Based on Raub Brock Capital Management's 13F filing for Q3 2016, filed 27 Oct 2016.